<div class="container">

<table style="width: 100%;"><tr>
<td>scABEL</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Scaled (widened) BE Acceptance Limits
</h2>

<h3>Description</h3>

<p>The (widened) scaled BE acceptance limits are calculated according to the 
regulatory settings of EMA, HC, FDA or via user defined regulatory settings.
</p>


<h3>Usage</h3>

<pre><code class="language-R">scABEL(CV, regulator)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>CV</code></td>
<td>

<p>Coefficient of variation (of the Reference) as ratio.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>regulator</code></td>
<td>

<p>Regulatory body settings for the widening of the BE acceptance limits.<br>
May be given as character from the choices <code>"EMA"</code>, <code>"HC"</code> (Health Canada), <code>"GCC"</code> (Gulf Cooperation Council), <code>"FDA"</code> or as an object of
class 'regSet' (see <code>reg_const</code>).<br>
Defaults to <code>regulator="EMA"</code> if missing.<br>
The former <code>regulator="ANVISA"</code> is no longer allowed. The ANVISA 
recommends since 2016 the EMA’s regulatory settings.<br>
The former <code>regulator="USER"</code> is no longer accepted but can be handled now
via function <code>reg_const()</code> to define an object with class 'regSet'.
</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p>The widened BE acceptance limits are calculated by the formula<br><code style="white-space: pre;">⁠  [L, U] = exp(-/+ r_const * sWR)⁠</code><br>
with <code>r_const</code> the regulatory constant and <code>sWR</code> the standard deviation of the within
subjects variability of the Reference.<br></p>

<ul>
<li> <p><code>regulator="EMA"</code> or <code>regulator="HC"</code><br><code>r_const = 0.76</code> (~ log(1.25)/sqrt(log(0.30^2+1)))
</p>
</li>
<li> <p><code>regulator="GCC"</code><br><code>r_const = 0.97997...</code> (= log(1/0.75)/sqrt(log(0.30^2+1)))
</p>
</li>
<li> <p><code>regulator="FDA"</code><br><code>r_const = 0.89257...</code> (= log(1.25)/0.25)
</p>
</li>
</ul>
<p>If the CVwR of the Reference is &lt; CVswitch=0.3 the conventional ABE limits 
apply (mixed procedure).<br><br> 
In case of <code>regulator="EMA"</code> a cap is placed on the widened limits if 
CVwR&gt;0.5, <em>i.e.</em>, the widened limits are held at the value calculated for CVwR=0.5.<br>
In case of <code>regulator="HC"</code> the capping is done such that the acceptance
limits are 0.6666 ... 1.5 at maximum, <em>i.e.</em>, CVcap=0.57382. 
Literally it is given by Health Canada rounded to three significant digits as 57.4%.
</p>


<h3>Value</h3>

<p>Returns a vector of lenghth 2 if one CV is given or a matrix if CV is given as vector 
with named components <code>lower</code> and <code>upper</code> of the scaled acceptance limits.
</p>


<h3>Note</h3>

<p>The scaled acceptance limits (coined <em>‘implied limits’</em> by Davit <em>et al.</em>) are not directly used in the BE evaluation for HVDP(s) recommended by the FDA. They are included here for comparative purposes. Moreover, there are controversies where to locate the <em>‘implied limits’</em> and whether the so-called ‘desired consumer-risk model’ should be used.
</p>


<h3>Author(s)</h3>

<p>D. Labes
</p>


<h3>References</h3>

<p>Davit BM, Chen ML, Conner DP, Haidar SH, Kim S, Lee CH, Lionberger RA, Makhlouf FT, Nwakama PE, Patel DT, Schuirmann DJ, Yu LX. <em>Implementation of a Reference-Scaled Average Bioequivalence Approach for 
Highly Variable Generic Drug Products by the US Food and Drug Administration.</em> AAPS J. 2012;14(4):915–24. <a href="https://doi.org/10.1208/s12248-012-9406-x">doi:10.1208/s12248-012-9406-x</a>
</p>
<p>Health Canada, Therapeutic Products Directorate. <em>Guidance Document. Comparative Bioavailability Standards:
Formulations Used for Systemic Effects.</em> 2018/06/08. <a href="https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/dhp-mps/alt_formats/pdf/prodpharma/applic-demande/guide-ld/bio/comparative-bioavailability-standards-formulations-used-systemic-effects.pdf">ISBN: 978-0-660-25514-9</a>
</p>


<h3>See Also</h3>

<p><code>power.scABEL, sampleN.scABEL, reg_const</code>
</p>


<h3>Examples</h3>

<pre><code class="language-R">scABEL(CV = 0.3, regulator = "EMA")
# should give the conventional (unscaled) BE limits:
# lower upper
#  0.80  1.25

scABEL(CV = 0.5, regulator = "EMA")
# should give the (maximum) expanded limits:
#     lower     upper
# 0.6983678 1.4319102

# define old ANVISA settings via reg_const()
rc      &lt;- reg_const("USER", r_const = 0.76,
                     CVswitch = 0.4, CVcap = 0.5)
rc$name &lt;- "ANVISAold"
scABEL(CV = 0.4, regulator = rc)
# should give the conventional (not expanded) limits:
# lower upper
#  0.80  1.25

scABEL(CV = 0.55, regulator = "HC")
# should give the widened limits:
#     lower     upper
# 0.6765789 1.4780241

scABEL(CV = 0.55, regulator = "GCC")
# should give the widened limits:
#    lower    upper
# 0.750000 1.333333

scABEL(CV = 0.55, regulator = "FDA")
# should give the 'implied' limits:
#     lower     upper
# 0.6320032 1.5822705
</code></pre>


</div>